Valion Bio (VBIO) General Counsel Melinda Lackey becomes reporting insider with Form 3

Rhea-AI Filing Summary

Valion Bio, Inc. disclosed that Melinda Lackey, its General Counsel & SVP of Legal, has become a reporting insider by filing an initial statement of beneficial ownership on Form 3. The filing establishes her status as an officer subject to insider reporting rules but does not list any reportable transactions.

Key Terms

General Counsel & SVP of Legal, reporting insider, ten percent owner

3 terms

General Counsel & SVP of Legal financial

"Lackey Melinda is listed as General Counsel & SVP of Legal"

reporting insider financial

"has become a reporting insider by filing an initial statement"

ten percent owner financial

"is_ten_percent_owner set to 0 for the reporting person"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 05/04/2026 - 04:07 PM Learn about SEC filing dates

FAQ

What does Melinda Lackey’s Form 3 filing mean for Valion Bio (VBIO)?

The Form 3 shows that Melinda Lackey, Valion Bio’s General Counsel & SVP of Legal, is now a reporting insider. It formally subjects her to ongoing SEC disclosure rules for future changes in her ownership of Valion Bio securities.

What role does Melinda Lackey hold at Valion Bio (VBIO)?

Melinda Lackey is listed as Valion Bio’s General Counsel & SVP of Legal. This makes her an executive officer, which is why she must file insider ownership reports such as Form 3 with the SEC for transparency around her holdings.

Does Valion Bio’s Form 3 for Melinda Lackey show any stock transactions?

The summarized data for Melinda Lackey’s Form 3 shows no reported buy, sell, exercise, gift, or other share transactions. It functions as an initial insider ownership statement without recording specific trades in Valion Bio securities.

Is Melinda Lackey reported as a 10% owner of Valion Bio (VBIO)?

The Form 3 data indicates Melinda Lackey is an officer but not a ten percent owner of Valion Bio. She files as General Counsel & SVP of Legal, reflecting her executive role rather than a large ownership stake in the company.

Are there any derivative securities reported for Melinda Lackey at Valion Bio?

The derivative section of the Form 3 summary for Melinda Lackey is empty, indicating no listed options, warrants, or other derivative positions in Valion Bio securities in this initial insider ownership filing with the SEC.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lackey Melinda

(Last) (First) (Middle)

1305 E. HOUSTON STREET

BLG. 1, STE. 311

(Street)

SAN ANTONIO TEXAS 78205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026

3. Issuer Name and Ticker or Trading Symbol
Valion Bio, Inc. [ VBIO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel & SVP of Legal

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Melinda Lackey	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)